Balaxi Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹62.29Cr |
Net Profits | ₹13.59Cr |
Net Profit Margins | 21.82% |
Highlights
Revenue:
Balaxi Pharmaceuticals Ltd’s revenue fell -24.06% since last year same period to ₹62.29Cr in the Q3 2023-2024. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 2.7% jump in its revenue since last 3-months.
Net Profits:
Balaxi Pharmaceuticals Ltd’s net profit jumped 65.13% since last year same period to ₹13.59Cr in the Q3 2023-2024. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -5.82% fall in its net profits since last 3-months.
Net Profit Margins:
Balaxi Pharmaceuticals Ltd’s net profit margin jumped 117.43% since last year same period to 21.82% in the Q3 2023-2024. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -8.3% fall in its net profit margins since last 3-months.
